| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bortezomib | cationic trypsinogen | NA | Successful target | TTD , DGIDB | Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] |
0.3 | approved | unknown |
| bortezomib | proteasome subunit beta type-1 | small molecule | NA | drugbank , DGIDB | Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] |
0.71 | approved,investigational | inhibitor |
| bortezomib | proteasome subunit beta type-5 | small molecule | NA | drugbank , DGIDB | Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] |
0.51 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||